| |
GENOVAC starts a project to develop blocking antibodies for the therapy of hepatitis C infections (AntiHepaC)
|
| |
| |
(pressebox) Freiburg, 18.09.2008 -
GENOVAC GmbH has started a research project funded by the German Ministry for Business and Technology (BMWi), as part of the program PRO INNO II, for the "Development and validation of antibodies as a novel therapeutic concept to block liver infection by hepatitis C Virus".__
According to Dr Fritz Grunert (CSO) the joint developmental project with the French partner INSERM U748, Strasbourg, aims to design, develop and pre-clinically validate the basics for a novel therapeutic approach in the prevention and treatment of hepatitis C (HCV) infections.__
The development of monoclonal antibodies that block epitopes of known cellular HCV receptors will be the focus of this project. Following a comprehensive characterisation, more functional-therapeutic research using in vitro liver cell models are planned. "We would like to develop a platform for a completely novel therapeutic concept in the treatment of HCV infections. A renowned scientific partner in this field, Prof. Thomas Baumert, Director of the Institute of Virology at the INSERM U748 will help us to achieve this goal", said Dr John Thompson, Managing Director of GENOVAC GmbH. "On completion, we then plan to test the antibodies in vivo in pre-clinical studies".__
First results from Prof. Baumert's group look extremely promising and will be presented at the upcoming "15th International Symposium on hepatitis C virus and related viruses" in San Antonio, Texas, USA from 5th -9th of October 2008.__
"After a consistent and successful expansion of our service portfolio during the last couple of years, we are now aiming to support our business model with own product developments. Our technology has the potential and together with the right partners, we shall successfully translate this into business", summarises Dr Stefan Lang, Director Business Development at GENOVAC GmbH.
Ansprechpartner:
Herr Dr. Stefan Lang_GENOVAC GmbH_Telefon: +49 (761) 45636-0_Fax: +49 (761) 45636-29_ Nachricht senden
GENOVAC GmbH_Telefon: +49 (761) 45636-0_Fax: +49 (761) 45636-29
|
|
| |
| |
|
|
|
